Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Gene therapy targets in postinfarction remodeling.
The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
Gene therapy targets in postinfarction remodeling.
Katz MG, Gubara SM, Eliyahu E. Gene therapy targets in postinfarction remodeling. J Thorac Cardiovasc Surg. 2020 05; 159(5):e305.
View in:
PubMed
subject areas
Genetic Therapy
Humans
Myocardial Infarction
Ventricular Remodeling
authors with profiles
Michael Katz